Importantly, these results suggest that systemic therapeutic silencing of Fsp27, although not effective in reducing hepatosteatosis, might not lead to a deleterious liver phenotype in this model of dietary obesity, as reported in HFD-fed mice after complete loss of FSP27 activity (23, 24). This evidence concerns the gene CIDEC and obesity disorder.